# FDA Inspection 1122323 - LifeSouth Community Blood Centers, Inc - February 27, 2020

Source: https://www.keypedia.com/records/fda_inspections/lifesouth-community-blood-centers-inc/2e37be53-ea07-46ee-8623-de38f5f89ecc
Source feed: FDA_Inspections

> FDA Inspection 1122323 for LifeSouth Community Blood Centers, Inc on February 27, 2020. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1122323
- Company Name: LifeSouth Community Blood Centers, Inc
- Inspection Date: 2020-02-27
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1250489 - 2024-09-12](https://www.keypedia.com/records/fda_inspections/lifesouth-community-blood-centers-inc/823bfba3-ee5d-4f5f-a2a2-59c65a9f4a3f)
- [FDA Inspection 1250489 - 2024-09-12](https://www.keypedia.com/records/fda_inspections/lifesouth-community-blood-centers-inc/0bf3b90a-675d-418f-b13b-2feced587fcc)
- [FDA Inspection 1222388 - 2023-11-09](https://www.keypedia.com/records/fda_inspections/lifesouth-community-blood-centers-inc/81245d9f-6f14-43af-b7b4-4a37f4a1e837)
- [FDA Inspection 1222388 - 2023-11-09](https://www.keypedia.com/records/fda_inspections/lifesouth-community-blood-centers-inc/50f5c8ca-ab39-46da-b7db-f6d8fc6e4a04)
- [FDA Inspection 1180902 - 2022-09-08](https://www.keypedia.com/records/fda_inspections/lifesouth-community-blood-centers-inc/0558e1be-b622-4780-a518-650964358bc0)

Company: https://www.keypedia.com/companies/lifesouth-community-blood-centers-inc/94ebe4e9-b648-4d51-a063-4ad00b617893

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d